UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Journal of the American College of Cardiology, ISSN 0735-1097, 07/2018, Volume 72, Issue 4, pp. 351 - 366
reduced ejection fraction | registry | dose | medication | Severity of Illness Index | Mineralocorticoid Receptor Antagonists - administration & dosage | United States - epidemiology | Age Factors | Humans | Middle Aged | Heart Failure - physiopathology | Male | Socioeconomic Factors | Heart Failure - drug therapy | Mineralocorticoid Receptor Antagonists - therapeutic use | Dose-Response Relationship, Drug | Stroke Volume | Quality Improvement | Registries - statistics & numerical data | Female | Aged | Angiotensin Receptor Antagonists - therapeutic use | Heart Failure - epidemiology | Adrenergic beta-Antagonists - administration & dosage | Drug Utilization - statistics & numerical data | Adrenergic beta-Antagonists - therapeutic use | Angiotensin Receptor Antagonists - administration & dosage | Practice Guidelines as Topic | Health care | Angiotensin-converting enzyme inhibitors | Drugs | Therapy | Cardiac arrhythmia | Health services | Medical records | Clinical trials | Cardiovascular disease | Secondary schools | Regulatory approval | Renal insufficiency | Enzyme inhibitors | Peptidyl-dipeptidase A | Blood pressure | Cardiology | Angiotensin II | Heart diseases | Age | Heart failure | Hypertension | Mortality | Hospitalization | Patients | Asthma | Heart rate | Ethnicity | Inhibitors | Coronary vessels | Angiotensin | Neprilysin | Diabetes | Clinical medicine | Females | Hispanics | Ejection fraction
Journal Article
International journal of cardiology, ISSN 0167-5273, 2016, Volume 227, pp. 272 - 277
Cardiovascular | Heart failure | Heart failure with reduced and preserved ejection fraction | Soluble source of tumorigenicity 2 | C-reactive protein | Growth-differentiation factor-15 | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Predictive Value of Tests | Prognosis | Humans | Middle Aged | Male | Biomarkers - blood | Heart Failure - blood | Stroke Volume | C-Reactive Protein - metabolism | Growth Differentiation Factor 15 - blood | Peptide Fragments - blood | Interleukin-1 Receptor-Like 1 Protein - blood | Adult | Female | Aged | Heart Failure - diagnosis | Natriuretic Peptide, Brain - blood | Heart Failure - mortality | Analysis | Biological markers | Index Medicus
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 08/2017, Volume 318, Issue 8, pp. 713 - 720
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Single-Blind Method | Humans | Middle Aged | Ventricular Dysfunction - drug therapy | Heart Failure - physiopathology | Hospitalization - statistics & numerical data | Male | Biomarkers - blood | Heart Failure - blood | Heart Failure - drug therapy | Stroke Volume | Heart Failure - therapy | Treatment Failure | Peptide Fragments - blood | Cardiovascular Diseases - mortality | Female | Aged | Natriuretic Peptide, Brain - blood | Heart failure | Heart | Brain natriuretic peptide | Therapy | Peptides | Risk groups | Mortality | Clinical trials | Patients | Risk factors | Biomarkers | Strategy | Titration | Drug therapy | Cardiovascular diseases | Heart diseases | Biochemical markers | Index Medicus | Abridged Index Medicus | heart failure with reduced ejection fraction | amino-terminal pro–B-type natriuretic peptide | patient outcomes
Journal Article
European journal of heart failure, ISSN 1388-9842, 09/2017, Volume 19, Issue 9, pp. 1186 - 1197
CARDIAC-FUNCTION | CARDIOMETABOLIC RISK | Heart failure with reduced ejection fraction | MINERALOCORTICOID RECEPTOR ANTAGONISM | Abdominal obesity | PARADOX | Eplerenone | WAIST CIRCUMFERENCE | ALDOSTERONE BLOCKADE | CARDIOVASCULAR-DISEASE | BODY-MASS INDEX | ADIPOCYTE DYSFUNCTION | ADIPOSE-TISSUE | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Mineralocorticoid Receptor Antagonists - administration & dosage | Heart Failure, Systolic - drug therapy | Spironolactone - administration & dosage | Humans | Middle Aged | Obesity, Abdominal - diagnosis | Obesity, Abdominal - metabolism | Mineralocorticoid Receptor Antagonists - adverse effects | Male | Treatment Outcome | Ventricular Dysfunction, Left - diagnosis | Ventricular Dysfunction, Left - mortality | Drug Monitoring - methods | Stroke Volume | Ventricular Dysfunction, Left - metabolism | Heart Failure, Systolic - metabolism | Aldosterone - metabolism | Obesity, Abdominal - complications | Female | Heart Failure, Systolic - diagnosis | Aged | Spironolactone - analogs & derivatives | Spironolactone - adverse effects | Heart Failure, Systolic - complications | Index Medicus | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Klinisk medicin
Journal Article
5.
Full Text
Murine Models of Heart Failure With Preserved Ejection Fraction: A “Fishing Expedition”
JACC. Basic to translational science, ISSN 2452-302X, 12/2017, Volume 2, Issue 6, pp. 770 - 789
Journal Article
JACC. Heart failure, ISSN 2213-1779, 10/2020, Volume 8, Issue 10, pp. 789 - 799
Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Pandemics | Humans | Natriuretic Peptide, Brain - metabolism | Heart Failure - physiopathology | Hospitalization - statistics & numerical data | Aminobutyrates - therapeutic use | COVID-19 | Cardiotonic Agents - therapeutic use | Dose-Response Relationship, Drug | Early Termination of Clinical Trials | SARS-CoV-2 | Betacoronavirus | Heart-Assist Devices | Coronavirus Infections | Peptide Fragments - metabolism | Glomerular Filtration Rate | Double-Blind Method | Heart Transplantation | Heart Failure - metabolism | Hypotension - chemically induced | Heart Failure - drug therapy | Stroke Volume | Pneumonia, Viral | Tetrazoles - therapeutic use | Angiotensin Receptor Antagonists - therapeutic use | Drug Combinations
Journal Article
European journal of heart failure, ISSN 1388-9842, 11/2020, Volume 22, Issue 11, pp. 2123 - 2133
Frailty | Heart failure with reduced ejection fraction | Outcomes | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Index Medicus | Kardiologi | Cardiac and Cardiovascular Systems | enalapril | index | risk | older-adults | biomarker
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 05/2019, Volume 73, Issue 19, pp. 2365 - 2383
Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Prospective Studies | Humans | Middle Aged | Heart Failure - physiopathology | Male | Heart Failure - drug therapy | Dose-Response Relationship, Drug | Stroke Volume | Ventricular Dysfunction, Left - drug therapy | Quality of Life | Female | Aged | Drug Therapy, Combination | Angiotensin-converting enzyme inhibitors | Heart | Drugs | Therapy | Identification methods | Clinical trials | Cardiovascular disease | Secondary schools | Multivariate analysis | Beta blockers | Confidence intervals | Enzyme inhibitors | Peptidyl-dipeptidase A | Education | Blood pressure | Angiotensin II | Heart diseases | Heart failure | Medical research | Family income | Enrollments | Hospitalization | Patients | Quality of life | Ethnicity | Inhibitors | Quality control | Angiotensin | Titration | Neprilysin | Clinical medicine | Ejection fraction
Journal Article
JACC. Heart failure, ISSN 2213-1779, 01/2019, Volume 7, Issue 1, pp. 13 - 21
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 07/2018, Volume 72, Issue 4, pp. 351 - 366
Journal Article
11.
Digoxin Discontinuation and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction
Journal of the American College of Cardiology, ISSN 0735-1097, 08/2019, Volume 74, Issue 5, pp. 617 - 627
Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | United States - epidemiology | Survival Rate - trends | Humans | Risk Factors | Heart Failure - physiopathology | Stroke Volume - physiology | Patient Readmission - trends | Male | Treatment Outcome | Withholding Treatment | Cause of Death | Heart Failure - drug therapy | Propensity Score | Cardiotonic Agents - administration & dosage | Outpatients | Digoxin - administration & dosage | Female | Registries | Aged | Retrospective Studies | Heart Failure - mortality | Heart failure | Angiotensin-converting enzyme inhibitors | Heart | Enzymes | Digoxin | Mortality | Clinical trials | Beta blockers | Patients | Discharge | Confidence intervals | Enzyme inhibitors | Peptidyl-dipeptidase A | Government programs | Angiotensin | Blood pressure | Health risk assessment | Heart diseases | Ejection fraction
Journal Article
Circulation journal : official journal of the Japanese Circulation Society, ISSN 1346-9843, 2017, Volume 81, Issue 7, pp. 1006 - 1013
LV diastolic function | B-type natriuretic peptide | Heart failure with reduced EF | Heart failure with preserved EF | LV concentric remodeling/hypertrophy | Age Factors | Humans | Middle Aged | Heart Failure - physiopathology | Male | Heart Failure - blood | Ventricular Dysfunction, Left - physiopathology | Aging - blood | Ventricular Remodeling | Ventricular Dysfunction, Left - blood | Sex Factors | Aged, 80 and over | Female | Aged | Natriuretic Peptide, Brain - blood | Index Medicus
Journal Article
13.
Effect of Empagliflozin on Hemodynamics in Patients With Heart Failure and Reduced Ejection Fraction
Journal of the American College of Cardiology, ISSN 0735-1097, 12/2020, Volume 76, Issue 23, pp. 2740 - 2751
Journal Article
JACC. Heart failure, ISSN 2213-1779, 10/2019, Volume 7, Issue 10, pp. 862 - 874
Journal Article